ArticleCannabis (Albuquerque, N.M.)2025
Cannabis Products and Use Patterns Associated with Cannabis Use Disorder Symptoms Among Youth in Southern California.
Article in Cannabis (Albuquerque, N.M.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Associations between modes of cannabis use and cannabis use disorder: Evidence from the 2022 to 2023 United States National Survey on Drug Use and Health.Addiction (Abingdon, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Objective: Cannabis use is common among adolescents. Limited research has examined how specific cannabis use behaviors may differentially increase cannabis use disorder (CUD) risk. Method: Data were from two waves of a prospective cohort of Southern California adolescents who used cannabis in the past six months ( Results: Most adolescents (69.8%) used >1 mode of cannabis in the past six-months; concentrates (vaped or dabbed) were the product type used most often (37.5%). Greater odds of CUD were observed for each additional cannabis product used in the past 6 months (vs. only one; adjusted odds ratio [AOR] range = 2.83-4.13; Conclusions: Frequent past-month cannabis use and using multiple modes of administration were predictors of probable CUD. In addition to monitoring the overall presence of adolescent cannabis use, these results demonstrate the importance of raising awareness about specific use behaviors associated with CUD risk among youth, particularly in regions with well-developed cannabis markets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.